These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


187 related items for PubMed ID: 35772508

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002.
    Williams LJ, Rasmussen SA, Flores A, Kirby RS, Edmonds LD.
    Pediatrics; 2005 Sep; 116(3):580-6. PubMed ID: 16140696
    [Abstract] [Full Text] [Related]

  • 4. Countries with an immediate potential for primary prevention of spina bifida and anencephaly: Mandatory fortification of wheat flour with folic acid.
    Kancherla V.
    Birth Defects Res; 2018 Jul 03; 110(11):956-965. PubMed ID: 29532629
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Spina bifida before and after folic acid fortification in Canada.
    De Wals P, Tairou F, Van Allen MI, Lowry RB, Evans JA, Van den Hof MC, Crowley M, Uh SH, Zimmer P, Sibbald B, Fernandez B, Lee NS, Niyonsenga T.
    Birth Defects Res A Clin Mol Teratol; 2008 Sep 03; 82(9):622-6. PubMed ID: 18655127
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States.
    Williams LJ, Mai CT, Edmonds LD, Shaw GM, Kirby RS, Hobbs CA, Sever LE, Miller LA, Meaney FJ, Levitt M.
    Teratology; 2002 Jul 03; 66(1):33-9. PubMed ID: 12115778
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Preventable spina bifida and anencephaly in Europe.
    Obeid R, Pietrzik K, Oakley GP, Kancherla V, Holzgreve W, Wieser S.
    Birth Defects Res A Clin Mol Teratol; 2015 Sep 03; 103(9):763-71. PubMed ID: 26178749
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Retrospective Assessment of Cost Savings From Prevention: Folic Acid Fortification and Spina Bifida in the U.S.
    Grosse SD, Berry RJ, Mick Tilford J, Kucik JE, Waitzman NJ.
    Am J Prev Med; 2016 May 03; 50(5 Suppl 1):S74-S80. PubMed ID: 26790341
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High potential for reducing folic acid-preventable spina bifida and anencephaly, and related stillbirth and child mortality, in Ethiopia.
    Dixon M, Kancherla V, Magana T, Mulugeta A, Oakley GP.
    Birth Defects Res; 2019 Nov 15; 111(19):1513-1519. PubMed ID: 31424635
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Update on prevention of folic acid-preventable spina bifida and anencephaly.
    Bell KN, Oakley GP.
    Birth Defects Res A Clin Mol Teratol; 2009 Jan 15; 85(1):102-7. PubMed ID: 19067404
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.